Private company
Opyl
Opyl (ASX: OPL) is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin (www.opin.ai) a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform (www.trialkey.ai) that predicts and designs optimized clinical trial protocols (plans), reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics.2 It was founded in 2013.1 It is headquartered in Berkeley.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- HeadquartersBerkeley1
- Websiteshareroot.co
- Legal formpublic company1
See how the biggest companies compare on our leaderboards
Opyl (ASX: OPL) is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin (www.opin.ai) a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform (www.trialkey.ai) that predicts and designs optimized clinical trial protocols (plans), reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..2
Timeline
- 2013Founded Founded1
Links
- Websiteshareroot.co1
- WikipediaOpyl
- WikidataQ25344675
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataOpyl on Wikidata
- 2WikipediaOpyl on Wikipedia